Tansna Therapeutics tansna.com

Follow

Public list: Pharma Startups (6570) Neuroscience Startups (947)

Tansna Therapeutics is a drug discovery and development company focused on novel therapies for the treatment of CNS disorders, with an initial focus on epilepsy. The company has identified a library of proprietary compounds that are derivatives of the marketed anesthetic propofol. These compounds are drug-like small-molecules, exhibit broad-spectrum CNS pharmacology, and are non-sedating.

Tansna Therapeutics is a drug discovery and development company focused on novel therapies for the treatment of CNS disorders, with an initial focus on epilepsy. The company has identified a library of proprietary compounds that are derivatives of th...Show all

Company (Alive / Active)

All investors data 3 Investors

Phone:

4320 Forest Park Avenue
Suite 303
St. Louis, 63108
Missouri, United States

Web Traffic

Rank: Show (-10)
Engagement (PVPU): Show (+1%)
Domain Authority Score: Show
Page Views Per Million (PVPM): Show
Reach Per Million: Show

1W
1M
6M
1Y

Login

1W
1M
6M
1Y

Login

1W
1M
6M
1Y

Login

1W
1M
6M
1Y

Login

SEO Statistics

Domain Authority Score	Show
Page Authority Score	Show
No. External Links	Show
No. Links	Show

Web Traffic Statistics - Growth

	Per Week	Per Month	Per 6 Months	Per Year
Rank	Login to see details
Page Views Per Million	Login to see details
Page Views Per User	Login to see details
Reach Per Million	Login to see details

Related Tansna Therapeutics Jobs

jobs by

Indeed job
search

Investors

Investor	Investor Type	Location	Participating Rounds

There is no Board of Directors data available for this company. Please select another tab.

There is no Competitors data available for this company. Please select another tab.

Patents

Title	Application Date	Patent Date	Status (Patent / Application)
2,5-dialkyl-4-h/halo/ether-phenol compounds	Nov 24, 2014	Apr 25, 2017	Patent
2,5-dialkyl-4-h/halo/ether-phenol compounds	Feb 27, 2017		Application